search
Back to results

Endocuff for Surveillance of Serrated Polyposis Syndrome

Primary Purpose

Polyposis

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Endocuff-assisted Colonoscopy
Sponsored by
Hospital Clinic of Barcelona
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Polyposis focused on measuring Serrated lesions, Surveillance, Colorectal cancer, Endocuff, Sessile serrated adenoma, Colonoscopy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

-Adults with diagnosis of Serrated Polyposis Syndrome undergoing surveillance colonoscopies after clearance of all lesions >=5mm

Exclusion Criteria:

  • Patients with known strictures
  • Partial or total colonic resection
  • Acute diverticulitis
  • Concomitant inflammatory bowel disease
  • Suspected or proven lower gastrointestinal bleeding
  • Non-correctable coagulopathy or anticoagulant/clopidogrel therapy during procedure
  • Inability to sign informed consent

Sites / Locations

  • María Pellisé. MD. PhD.

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Endocuff-assisted Colonoscopy

Standard Colonoscopy

Arm Description

Endocuff-assisted Colonoscopy with the ARC Endocuff-vision® attached at the distal tip of the scope.

Standard Colonoscopy without any additional device

Outcomes

Primary Outcome Measures

Number of serrated lesions >=5mm
Number of serrated lesions >=5mm detected in each arm

Secondary Outcome Measures

Number of total polyps
Number of total polyps in each arm
Number of serrated lesions >=10mm
Number of serrated lesions >=10mm detected in each arm
Number of serrated lesions with displasia
Number of serrated lesions with displasia in each arm
Number of adenomas
Number of adenomas in each arm
Number of advanced adenomas
Number of advanced adenomas in each arm
Number of flat lesions
Number of flat lesions in each arm
Number of flat lesions in right colon
Number of flat lesions in right colon in each arm
Withdrawal time
Extubation time from the cecum to scope removal from the anus, with exception of time taken for any therapeutic intervention
Total procedure time
Starting with endoscope insertion and withdrawal time including therapeutic interventions
Proportion of major adverse events
Colonic perforation or clinically significant bleeding
Proportion of minor adverse events
Superficial mucosal erosions in the colonic mucosa, abdominal pain and bloating

Full Information

First Posted
October 29, 2015
Last Updated
August 3, 2017
Sponsor
Hospital Clinic of Barcelona
Collaborators
Fundacion Clinic per a la Recerca Biomédica
search

1. Study Identification

Unique Protocol Identification Number
NCT02592603
Brief Title
Endocuff for Surveillance of Serrated Polyposis Syndrome
Official Title
Endocuff-assisted vs. Standard Colonoscopy for Surveillance of Serrated Polyposis Syndrome: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
October 2015 (undefined)
Primary Completion Date
July 2017 (Actual)
Study Completion Date
July 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Clinic of Barcelona
Collaborators
Fundacion Clinic per a la Recerca Biomédica

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Serrated Polyposis Syndrome (SPS) is a high-risk condition for colorectal cancer (CRC). SPS patients have a cumulative CRC risk of 1.9% in 5 years despite a strict endoscopic surveillance in specialized centers. Proximal serrated lesions are endoscopically challenging to detect due to their unremarkable morphology. Endocuff is a novel device comprised of a cap with a row of finger-like projections with a unique dynamic shape that help to flatten mucosal folds during withdrawal of the instrument in order to improve detection of lesions. Recent studies have reported an increase of detection rate and mean per patient of adenomas with Endocuff-assisted Colonoscopy compared with Standard Colonoscopy. The purpose of this study is to assess the usefulness of Endocuff-assisted Colonoscopy to detect serrated lesions in SPS patients undergoing surveillance compared to Standard Colonoscopy in a randomized fashion
Detailed Description
According to own data and similarly to previous published studies, patients diagnosed of Serrated Polyposis Syndrome undergoing annual surveillance after clearance of all serrated lesions ≥ 5mm, have a mean of 5 serrated lesions per patient at follow-up colonoscopies. The study was powered to establish a 25% significant increase in the mean of serrated lesions per patient in the Endocuff-assisted colonoscopy group. Accepting an alpha risk of 0.05, a beta risk of 0.2 and a loss rate of 10% in a bilateral contrast, a sample size of 124 patients (62 in each arm) are required to achieve statistic significance.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Polyposis
Keywords
Serrated lesions, Surveillance, Colorectal cancer, Endocuff, Sessile serrated adenoma, Colonoscopy

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
125 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Endocuff-assisted Colonoscopy
Arm Type
Active Comparator
Arm Description
Endocuff-assisted Colonoscopy with the ARC Endocuff-vision® attached at the distal tip of the scope.
Arm Title
Standard Colonoscopy
Arm Type
No Intervention
Arm Description
Standard Colonoscopy without any additional device
Intervention Type
Device
Intervention Name(s)
Endocuff-assisted Colonoscopy
Other Intervention Name(s)
ECC
Intervention Description
Colonic examination with Endocuff-assisted Colonoscopy
Primary Outcome Measure Information:
Title
Number of serrated lesions >=5mm
Description
Number of serrated lesions >=5mm detected in each arm
Time Frame
one year
Secondary Outcome Measure Information:
Title
Number of total polyps
Description
Number of total polyps in each arm
Time Frame
one year
Title
Number of serrated lesions >=10mm
Description
Number of serrated lesions >=10mm detected in each arm
Time Frame
one year
Title
Number of serrated lesions with displasia
Description
Number of serrated lesions with displasia in each arm
Time Frame
one year
Title
Number of adenomas
Description
Number of adenomas in each arm
Time Frame
one year
Title
Number of advanced adenomas
Description
Number of advanced adenomas in each arm
Time Frame
one year
Title
Number of flat lesions
Description
Number of flat lesions in each arm
Time Frame
one year
Title
Number of flat lesions in right colon
Description
Number of flat lesions in right colon in each arm
Time Frame
one year
Title
Withdrawal time
Description
Extubation time from the cecum to scope removal from the anus, with exception of time taken for any therapeutic intervention
Time Frame
30 minutes
Title
Total procedure time
Description
Starting with endoscope insertion and withdrawal time including therapeutic interventions
Time Frame
30 minutes
Title
Proportion of major adverse events
Description
Colonic perforation or clinically significant bleeding
Time Frame
Two weeks
Title
Proportion of minor adverse events
Description
Superficial mucosal erosions in the colonic mucosa, abdominal pain and bloating
Time Frame
Two weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: -Adults with diagnosis of Serrated Polyposis Syndrome undergoing surveillance colonoscopies after clearance of all lesions >=5mm Exclusion Criteria: Patients with known strictures Partial or total colonic resection Acute diverticulitis Concomitant inflammatory bowel disease Suspected or proven lower gastrointestinal bleeding Non-correctable coagulopathy or anticoagulant/clopidogrel therapy during procedure Inability to sign informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
María Pellisé, MD. PhD
Organizational Affiliation
Hospital Clinic of Barcelona
Official's Role
Principal Investigator
Facility Information:
Facility Name
María Pellisé. MD. PhD.
City
Barcelona
ZIP/Postal Code
08036
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
26264224
Citation
Carballal S, Rodriguez-Alcalde D, Moreira L, Hernandez L, Rodriguez L, Rodriguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, Gonzalez M, Moya E, Oquinena S, Clofent J, Quintero E, Esteban P, Pinol V, Fernandez FJ, Jover R, Cid L, Lopez-Ceron M, Cuatrecasas M, Lopez-Vicente J, Leoz ML, Rivero-Sanchez L, Castells A, Pellise M, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study. Gut. 2016 Nov;65(11):1829-1837. doi: 10.1136/gutjnl-2015-309647. Epub 2015 Aug 11.
Results Reference
background
PubMed Identifier
24921209
Citation
Biecker E, Floer M, Heinecke A, Strobel P, Bohme R, Schepke M, Meister T. Novel endocuff-assisted colonoscopy significantly increases the polyp detection rate: a randomized controlled trial. J Clin Gastroenterol. 2015 May-Jun;49(5):413-8. doi: 10.1097/MCG.0000000000000166.
Results Reference
background
PubMed Identifier
25470133
Citation
Floer M, Biecker E, Fitzlaff R, Roming H, Ameis D, Heinecke A, Kunsch S, Ellenrieder V, Strobel P, Schepke M, Meister T. Higher adenoma detection rates with endocuff-assisted colonoscopy - a randomized controlled multicenter trial. PLoS One. 2014 Dec 3;9(12):e114267. doi: 10.1371/journal.pone.0114267. eCollection 2014.
Results Reference
background
PubMed Identifier
26171436
Citation
Sawatzki M, Meyenberger C, Marbet UA, Haarer J, Frei R. Prospective Swiss pilot study of Endocuff-assisted colonoscopy in a screening population. Endosc Int Open. 2015 Jun;3(3):E236-9. doi: 10.1055/s-0034-1391418. Epub 2015 Feb 27.
Results Reference
background
PubMed Identifier
31174224
Citation
Rivero-Sanchez L, Lopez Vicente J, Hernandez Villalba L, Puig I, Arnau-Collell C, Moreno L, Diaz M, Rodriguez de Miguel C, Ocana T, Moreira L, Cuatrecasas M, Carballal S, Sanchez A, Ortiz O, Llach J, Balaguer F, Pellise M; EndoCAR group from the Spanish Gastroenterology Association and the Spanish Society of Digestive Endoscopy. Endocuff-assisted colonoscopy for surveillance of serrated polyposis syndrome: a multicenter randomized controlled trial. Endoscopy. 2019 Jul;51(7):637-645. doi: 10.1055/a-0925-4956. Epub 2019 Jun 7.
Results Reference
derived

Learn more about this trial

Endocuff for Surveillance of Serrated Polyposis Syndrome

We'll reach out to this number within 24 hrs